Literature DB >> 19465895

Diabetes: The HEART2D trial--new questions beyond answers.

Louis Monnier, Claude Colette.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19465895     DOI: 10.1038/nrendo.2009.98

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  8 in total

1.  Biochemistry and molecular cell biology of diabetic complications.

Authors:  M Brownlee
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

2.  The effect of glucose variability on the risk of microvascular complications in type 1 diabetes.

Authors:  Eric S Kilpatrick; Alan S Rigby; Stephen L Atkin
Journal:  Diabetes Care       Date:  2006-07       Impact factor: 19.112

3.  Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.

Authors:  Louis Monnier; Emilie Mas; Christine Ginet; Françoise Michel; Laetitia Villon; Jean-Paul Cristol; Claude Colette
Journal:  JAMA       Date:  2006-04-12       Impact factor: 56.272

4.  Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes.

Authors:  Rury R Holman; Kerensa I Thorne; Andrew J Farmer; Melanie J Davies; Joanne F Keenan; Sanjoy Paul; Jonathan C Levy
Journal:  N Engl J Med       Date:  2007-09-21       Impact factor: 91.245

5.  Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial.

Authors:  Reinhard G Bretzel; Ulrike Nuber; Wolfgang Landgraf; David R Owens; Clare Bradley; Thomas Linn
Journal:  Lancet       Date:  2008-03-29       Impact factor: 79.321

6.  Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial--revisited.

Authors:  John M Lachin; Saul Genuth; David M Nathan; Bernard Zinman; Brandy N Rutledge
Journal:  Diabetes       Date:  2008-01-25       Impact factor: 9.461

7.  Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial.

Authors:  Itamar Raz; Peter W F Wilson; Krzysztof Strojek; Irina Kowalska; Velimir Bozikov; Anselm K Gitt; György Jermendy; Barbara N Campaigne; Lisa Kerr; Zvonko Milicevic; Scott J Jacober
Journal:  Diabetes Care       Date:  2009-03       Impact factor: 19.112

8.  Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  David M Nathan; John B Buse; Mayer B Davidson; Ele Ferrannini; Rury R Holman; Robert Sherwin; Bernard Zinman
Journal:  Diabetes Care       Date:  2008-10-22       Impact factor: 17.152

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.